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The endogenous cannabinoid system (ECS) regulates a broad number of physiological processes, and perturbations in its normal functioning are linked to many disorders. [1] In this respect, the development of high-sensitivity and highthroughput analytical tools that afforded a broader view of the ECS would be highly valuable. As such, small-molecule fluorescent probes could provide dynamic information concerning the direct spatial and temporal expression levels of cannabinoid receptors as has been recently reported for some specific classes of enzymes. [2] Accordingly, the development of small-molecule probes that are able to recognize cannabinoid receptors is an area of current interest, because they could complement and even overcome some of the drawbacks of the available antibodies. [3] Recent attempts toward this goal have been mainly focused on the CB 2 receptor (CB 2 R = cannabinoid receptor type 2). However, these probes show moderate affinities [K i = (260-387) nm], and their application in native systems is limited. [4] Similarly, endocannabinoidbased probes display modest affinities for CB 1 and CB 2 receptors [(84.7-450) nm], [5] a fact that could limit their use in complex systems. Therefore, we focused our efforts on the synthetic high-affinity cannabinoid ligands HU210 [K i (CB 1 R) = 0.061 nm, K i (CB 2 R) = 0.52 nm], [6] and HU308 [K i (CB 1 R) > 10 000 nm, K i (CB 2 R) = 22.7 nm] [7] (Scheme 1). Among the different tags, biotin was selected owing to its versatility for detection by a variety of readily available (strept)avidin conjugates. A closer look to the structure of these ligands revealed that the most straightforward possibility was to attach the tag at the free hydroxy groups (Scheme 1).
Ligand HU210 was prepared as previously described. [8] For the introduction of the tag, we made some attempts to selectively acylate the allylic hydroxy group using either Mitsunobu conditions [9] or the HfCl 4 ·2 THF catalyst. [10] However, none of them gave good yields in our hands and we carried out the reaction between ligand HU210 and N-(+)-biotinyl-6-aminohexanoic acid in the presence of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide and 4-dimethylaminopyridine. Under these conditions, formation of bisacylated product was not observed, starting material was partly recovered, and compounds 1 and 2 were obtained after separation by column chromatography with 25 % and 14 % yields, respectively. Ligand HU308 was obtained as previously described [7] from commercially available a-pinene. Esterification of ligand HU308 with N-(+)-biotinyl-6-aminohexanoic acid gave derivative 3 in 55 % yield. Compounds 1-3 were tested for their affinities to CB 1 and CB 2 receptors, showing K i values in the nanomolar range (Table 1) . It is especially relevant that probes 1 and 2, derived from ligand HU210, keep a high affinity for both cannabinoid receptors and that probe 3 keeps the selectivity feature of its parent compound, HU308, with high affinity for the CB 2 receptor whilst being inactive at the CB 1 receptor.
To propose structural hypotheses for the binding of these compounds, we constructed three-dimensional models of the CB 1 and CB 2 receptors using the crystal structure of the homologous sphingosine 1-phosphate receptor 1 (S1P 1 ) [11] as a template (the Supporting Information and Figure S1 ). Docking of ligands HU210 and HU308 into the receptor models (the Supporting Information and Figure S2 ) places the hydroxy groups pointing toward the extracellular environment. However, the entrance of the ligand into the binding pocket has been proposed very recently to be from the lipid bilayer, in particular through an opening between transmembrane helices (TMs) 1 and 7 (Figure 1 A) . [11] Thus, in ligand HU210, the hydroxy group attached to the phenyl ring is more distant to this opening than its allylic hydroxy group. As a consequence, probes 1 (Figure 1 A, B ) and 3 (Figure 1 C) expand their biotin chains through this channel more favorably than probe 2 (not shown). Importantly, attachment of the biotin chain to ligands HU210 or HU308 decreases the binding affinity in a more pronounced manner in CB 1 R than CB 2 R (Table 1) . According to the Ballesteros-Weinstein numbering scheme the side chains at positions 1.32 (Q in CB 1 R and K in CB 2 R), 1.35 (I in CB 1 R and V in CB 2 R), 7.34 (V in CB 1 R and A in CB 2 R), and 7.36 (A in CB 1 R and A in CB 2 R) define this channel between TMs 1 and 7. Thus, we hypothesize that this effect is due to the presence of amino acid residue K1.32 in the CB 2 receptor, which stabilizes the carbonyl group of the biotin chain in a more significant manner than residue Q1.32 of the CB 1 receptor.
Compounds 1-3 were used for in vitro labeling of cannabinoid receptors in transiently transfected hippocampal neuronal (HT22) cells (data not shown). In these experiments, probe 1 performed better than 2, either because of the higher exposure of the biotin moiety as suggested by the computational model or because of the slightly higher affinity for CB 1 R (Table 1) . Therefore, we selected probes 1 and 3 for their use in native systems, and neurons and microglia were chosen as relevant systems for CB 1 and CB 2 receptors, respectively. Probe 1 is able to label neurons in primary culture (Figure 2 A, B) . Next, we checked the specificity of the labeling by parallel experiments in the presence of an excess of ligand HU210, which abolished labeling (Figure 2 C) . As expected, probe 3, with no affinity for CB 1 R, did not show any significant fluorescence in neurons (Figure 2 D) . Notably, this labeling is fully compatible with the simultaneous use of primary antibodies in colabeling studies (Figure 3 ). Probe 1 shows the predominant location of CB 1 receptor in the neuronal soma (Figure 3 A) , whereas the anti-MAP2 antibody labels the entire neuron (Figure 3 B) , including axon and dendrites, as expected from this marker. Labeling of CB 1 receptor by probe 1 (Figure 3 D) is further confirmed by double staining with a commercial antibody against this receptor (Figure 3 E, F) .
To further explore the potential of the probes in a different native cell system, we assessed their performance in micro- glial cells, also known as the macrophages of the brain. These cells express CB 2 R, which is believed to play a fundamental role in their immune-related functions. [12] In agreement with the binding profile of the probes, both probes 1 and 3 allowed visualization of CB 2 R in microglia (Figure 4 A, B) but not in the presence of an excess of ligand HU210 (Figure 4 C) . Again, the intensity of the fluorescence signal is comparable with the one obtained with an antibody against the microglial marker Iba-1 (Figure 4 D) .
Importantly, in microglial cells, labeling with probe 3 clearly reflects the changes in CB 2 R expression between a resting state ( Figure 5 , panels A-C) and an activated (proinflammatory) phenotype induced by lipopolysaccharide (LPS) exposure ( Figure 5, panels D-F) .
Considering the relevance of the ECS in the regulation of the immune system we studied the potential of these probes in flow cytometry. The application of this methology would facilitate the profiling of cannabinoid receptors at the single- cell level and could contribute to shed light on the function of the ECS in the immune system, a field of utmost current interest. [13] Probes were tested in the monocytic cell line THP-1, which has been described to have a functional endocannabinoid system. [14] Cells were incubated with probe 1 (1 mm) and then stained with streptavidin-Alexa Fluor 488 and analyzed by flow cytometry (Figure 6 ). Although the expression of CB 1 and CB 2 receptors is moderate in unstimulated THP-1 cells as assessed by western blot (data not shown), our experiments cleary demonstrate the suitability of probe 1 to visualize cannabinoid receptors in this cell line by flow cytometry.
In conclusion, the probes described herein are, to our knowledge, the first small-molecule tools suitable for visualization of CB 1 and CB 2 receptors in native cell systems of physiological relevance with at least comparable potency to antibodies. Taking into account the practical limitations that these antibodies have, these probes increase the arsenal of chemical tools for the study of cannabinoid receptors and may help to dissect the complex roles of the ECS. Further extension of the versatility of this approach is currently ongoing.
